GKOS Completes Enrollment
Glaukos completes patient enrollment in Phase 2 study of GLK-321 for Demodex Blepharitis
GKOS - Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
Glaukos completes patient enrollment in Phase 2 study of GLK-321 for Demodex Blepharitis
GKOS - Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis